WuXi PharmaTech Recognized for R&D Excellence By Shanghai Authorities
Nov 01, 2004
November 01, 2004 - Shanghai, China - WuXi PharmaTech Co., Ltd., a leading chemistry R&D outsourcing services company, has been recognized as one of the premier R&D Institutions in Pudong, Shanghai by the Shanghai Pudong New Area People's Government. Companies from across all high-tech industries were considered for this award. WuXi PharmaTech was selected because of its strong R&D capability and its substantial capital investment in advanced research instrumentation and state-of-the-art infrastructure. After rigorous on-site scrutiny by the authorities, WuXi PharmaTech received the award, which included a certificate, a medal and tax benefits from Shanghai Pudong Science & Technology Bureau and Shanghai Pudong Finance & Tax Bureau."WuXi PharmaTech continues to set a solid example for the Chinese pharmaceutical industry, as well as other high-tech industries"according to the statement from the Shanghai authorities. Other recipients of the award included: General Electric (China) R&D Center, Shanghai Genomics, etc.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.